They support an arrangement that aids their nation, but worry it might be too late for one of the largest mines in Europe.

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

The Indianapolis-based drugmaker also reaffirmed its 2025 revenue guidance but noted that the calculation was based on existing tariff and trade policies.

Trump hosted top CEOs at the White House to announce over $8 trillion in U.S. investments. From AI chips to steel, here’s who ...

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

President Donald Trump granted a lengthy interview to Time magazine in honor of completing his first 100 days of his second ...

Regeneron Pharmaceuticals, Inc. REGN reported first-quarter 2025 adjusted earnings per share (EPS) of $8.22, which missed the ...

Executives at some of the world's biggest companies are faced with the tricky task of explaining how President Donald Trump's ...

NEW YORK (Reuters) -A bruising rollercoaster ride for markets in the first 100 days of the Trump administration has seen some ...

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

On this episode of The Long View, Cullen Roche, the founder and chief investment officer of Discipline Funds, discusses how ...